Description

You will lead clinical development and medical strategy for Natera's molecular diagnostics in GU cancers. You'll design studies, engage KOLs, translate liquid biopsy technology into practice, and support medical affairs to improve patient outcomes.

Requirements

• M.D. with board certification or eligibility in Radiation Oncology
• At least 3 years post-residency clinical experience in GU cancers
• Deep knowledge of treatment paradigms in GU cancers
• Minimum 3 years clinical trial experience in academic, biotech, or pharmaceutical settings
• Willingness to travel >40%

Responsibilities

• Develop and execute clinical strategies for GU oncology molecular diagnostics
• Lead design and implementation of clinical studies integrating Natera's technology
• Recruit and engage principal investigators and clinical sites in GU oncology
• Advise on product development for GU oncology portfolio
• Provide post-launch medical affairs support including test interpretation and clinical consultation